Form4insider filings, from the source

SEC Form 4 · accession 0001140361-16-080556

Tobira Therapeutics, Inc. · TBRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Sep 20, 2016
Accepted (ET)
Sep 22, 2016 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311596

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.001 per shareF1Sep 20, 2016P1,070,000$39.03A2,979,000IBy managed account
Common Stock, par value $0.001 per shareF1Sep 20, 2016P1,000$39.23A2,980,000IBy managed account
Common Stock, par value $0.001 per shareF1Sep 20, 2016P220,000$38.87A3,200,000IBy managed account
Common Stock, par value $0.001 per shareSep 20, 2016P5,000$39.07A3,205,000IBy Matthew Halbower
Common Stock, par value $0.001 per shareSep 21, 2016P3,200$39.12A3,208,200IBy David Pickering
Common Stock, par value $0.001 per shareF1Sep 21, 2016P31,000$38.97A3,239,200IBy managed account
Common Stock, par value $0.001 per shareSep 21, 2016P195,000$39.14A3,434,200IBy Matthew Halbower
Common Stock, par value $0.001 per shareF1Sep 22, 2016P1,209$39.26A3,435,409IBy managed account
Common Stock, par value $0.001 per shareF1Sep 22, 2016P50,000$39.30A3,485,409IBy managed account
Common Stock, par value $0.001 per shareF1Sep 22, 2016P27,791$39.40A3,513,200IBy managed account
Common Stock, par value $0.001 per shareF1Sep 22, 2016P20,000$39.45A3,533,200IBy managed account

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses